Skip to main content
Boryung Corporation logo

Boryung Corporation — Investor Relations & Filings

Ticker · 003850 ISIN · KR7003850005 KO Manufacturing
Open in API
Filings indexed 354 across all filing types
Latest filing 2022-08-25 Regulatory Filings
Country KR South Korea
Listing KO 003850

About Boryung Corporation

https://pharm.boryung.co.kr/eng/index.do

Boryung Corporation is a fully integrated healthcare company founded in 1957. Its core business encompasses the research, development, manufacturing, and global commercialization of pharmaceutical products, with a significant presence in the cardiovascular therapeutic area. The company is distinguished by its pioneering 'Care in Space' (CIS) initiative, which focuses on developing healthcare solutions for humans in extreme environments and leveraging space for new research opportunities. In addition to its pharmaceutical operations, Boryung functions as a healthcare investment company, fostering innovation across the health sector. The company's diverse portfolio includes prescription drugs, over-the-counter products, and a pipeline aimed at addressing future medical needs.

Recent filings

Filing Released Lang Actions
불성실공시법인지정
Regulatory Filings Classification · 100% confidence The document is an official notice from the Korea Exchange (KRX) regarding the designation of Boryung as an 'unfaithful disclosure corporation' due to a delay in disclosing clinical trial results. This is a regulatory announcement concerning compliance and disclosure violations. Since it does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2022-08-25 Korean
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Boryung Corporation, covering the period from January 1, 2022, to June 30, 2022. It contains comprehensive financial data, including balance sheets, income statements, and detailed business operations, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-16 Korean
투자판단관련주요경영사항
Regulatory Filings Classification · 100% confidence The document is a regulatory disclosure from Boryung regarding the approval of a Phase 3 clinical trial for a new hypertension drug (BR1015) by the Korean Ministry of Food and Drug Safety (MFDS). It follows the standard format for 'Major Management Matters' (투자판단 관련 주요경영사항) filings in the Korean market, which are used to inform investors of significant operational or regulatory developments. Since it does not fit into specific categories like financial reports, dividends, or director dealings, it is classified as a general regulatory filing.
2022-08-03 Korean
불성실공시법인지정예고
Regulatory Filings Classification · 100% confidence The document is a formal notice from the Korea Exchange (KRX) regarding a 'Notice of Designation as an Unfaithful Disclosure Corporation' (불성실공시법인지정예고) for Boryung. This is a regulatory notification concerning a disclosure violation (delayed disclosure of clinical trial approval). Since it is a regulatory announcement regarding compliance and potential penalties, it falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A, dividends, or financial reports.
2022-08-03 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Boryung, detailing quarterly financial highlights such as revenue, operating profit, and net income for Q2 2022. It provides key financial metrics in a summary table format, which is characteristic of an initial earnings announcement rather than a full quarterly report or a report publication announcement. Therefore, it fits the definition of an Earnings Release (ER). Q2 2022
2022-07-27 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 1,000 characters) notifying the public of an upcoming Investor Relations (IR) meeting/presentation. It provides the date, location, and purpose of the meeting, and directs readers to the company website to access the actual IR materials. Per the 'Menu vs Meal' rule, this is an announcement of a report/presentation rather than the presentation itself, and it fits the definition of a Report Publication Announcement (RPA) or a general regulatory filing regarding an event.
2022-07-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.